Pure Global AI
jRCT1031220116Recruitment Completed

Untitled Trial

Real world Effectiveness and Safety of Trifluridine/Tipiracil plus bevacizumab in Metastatic Colorectal Cancer: A retrospective observational study using an administrative database
Taiho Pharmaceutical Co., Ltd.Japan Registry Clinical Trial
VerifiedJapan Registry Clinical Trial
Study focus
Disease/Condition
Colorectal cancer
Study type
Observational
Sponsor & location
Primary sponsor
Taiho Pharmaceutical Co., Ltd.
Timeline & enrollment
Phase
N/A
Start date
N/A
End date
N/A
ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
Registry
Japan Registry Clinical Trial
Trial ID
jRCT1031220116
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for jRCT1031220116 through Pure Global AI's free database. This phase not specified trial is sponsored by Taiho Pharmaceutical Co., Ltd. and is currently Recruitment Completed. The study focuses on Colorectal cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.